Replies to post #63305 on NorthWest Biotherapeutics Inc (NWBO)

[DoGood_DoWell]

I don't think many would agree with you. I and others would likely vigorously oppose it. Definitely not before the trials are done and the results announced and the market has a chance to reflect upon the outcome

[iwasadiver]

That will never happen. And it won't be necessary in my opinion.

[Sojourner55]

Selling would provide immediate gratification so traders can make a quick buck and move on to their next target. The long term value in this company is buy and hold until L is approved and the potential of D is realized. This is akin to holding Google or MSFT in its early stages.The payoff could be enormous compared with what we might get now.

My 2 cents.

[PacificNW]

I believe they have that covered, the price is so low now that the completely separate and independent company Cognate would be able to purchase it on the cheap shortly imho.

[doingmybest]

I think their plan has been to get value for shareholders by holding on until they get phase 3 done. That would be the time to either sell or partner for the more significant clinical program that is now needed. I think they can limp across the finish line of phase 3 and I am hopeful the second half of this year is much more fun that the first. The key is for the regulatory issue/opportunity to clear up and it is still the real timing wildcard here.